Skip to main content
Top

Diabetologia

Issue 9/1997

Content (16 Articles)

Originals

Improved outcome of islet transplantation in insulin-treated diabetic mice: effects on beta-cell mass and function

J. F. Merino, V. Nacher, M. Raurell, O. Aranda, J. Soler, E. Montanya

CD8 cytotoxic T-cell clone rapidly transfers autoimmune diabetes in very young NOD and MHC class I-compatible scid mice

R. Yoneda, K. Yokono, M. Nagata, Y. Tominaga, H. Moriyama, K. Tsukamoto, M. Miki, N. Okamoto, H. Yasuda, K. Amano, M. Kasuga

Role of hepatocyte growth factor in endothelial regulation: prevention of high D-glucose-induced endothelial cell death by prostaglandins and phosphodiesterase type 3 inhibitor

R. Morishita, J. Higaki, S.-I. Hayashi, Y. Yo, M. Aoki, S. Nakamura, A. Moriguchi, H. Matsushita, K. Matsumoto, T. Nakamura, T. Ogihara

A circadian rhythm in lipid mobilization which is altered in IDDM

E. Hagström-Toft, J. Bolinder, U. Ungerstedt, P. Arner

Rapid communication

Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy

R. Burgos, R. Simó, L. Audí, C. Mateo, J. Mesa, M. García-Ramírez, A. Carrascosa

The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris Prospective Study

M. A. Charles, E. Eschwe`ge, N. Thibult, J.-R. Claude, J.-M. Warnet, G. E. Rosselin, J. Girard, B. Balkau

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine